secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001425450-24-000031
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q1 revenue up 41% to $44.7M; raises FY 2024 guidance to $200-203M
--------------------------------------------------------------------------------

- Total revenue $44.7M (+41% YoY); U.S. +44%, international +33%.
- Net loss $7.8M ($0.34 loss per share) vs $6.8M ($0.30) a year ago.
- Adjusted EBITDA loss improved to $1.1M from $2.1M in Q1 2023.
- Raised full-year 2024 revenue guidance to $200-203M from prior $197-200M.
- Boston O&P acquisition contributed; cash & restricted cash $49.7M at March 31.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000031/0001425450-24-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000031/kids-20240506.htm
  HTML page:      https://secwatch.observer/filing/0001425450-24-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer